Exisulind On The Horizon

A study which was funded by Cell Pathways Inc., developer of the drug Exisulind, suggest that Exisulind may delay disease progression in men with recurrent prostate cancer according to Dr. Erik Goluboff, Assistant Professor of Urology at Columbia University College of Physicians & Surgeons, Director of Urology at The Allen Pavilion of New York-Presbyterian Hospital, [...]

HIFU For Recurrent Prostate Cancer

High Intensity Focused Ultrasound (HIFU) is a minimally invasive procedure that uses ultrasound energy to destroy cancerous tissue with focused sound waves. It has been used for a period of time in both Europe and Mexico as a primary prostate cancer treatment. Currently, in the United States there is a phase III trial being conducted [...]

By |2017-10-19T10:57:01-04:00September 26th, 2008|Advanced Prostate Cancer, Clinical Trials, HIFU, Uncategorized|0 Comments

Radiation Plus Hormone Therapy Cuts Prostate Cancer Mortality by 50% in men with Locally Advanced Disease

Investigators have reported, at the American Society for Therapeutic Radiation and Oncology (ASTRO) 50th Annual Meeting, that when radiation is added to anti-androgen therapy (ADT), survival rates are increased by 50% in men receiving only ADT. "This randomized trial is the first to show that men with locally advanced prostate cancer will survive substantially longer [...]

Procrit To Counter Anemia With ADT & Chemotherapy

It is common knowledge that androgens play a role in the production of red blood cells. The lack of androgens cause the hematocrit (proportion of blood volume that is occupied by red blood cells) level to fall in most men with prostate cancer who are on a hormone blockade. About 10% of men on a [...]

Docetaxel-Based Chemotherapy in Elderly Patients (Age 75 and Older) with Castration-Resistant Prostate Cancer Is Viable

There have been very few studies on the patterns of care and outcome of elderly (over 75 years) survivors with androgen independent prostate cancer (AIPC) who have been treated with docetaxel (Taxotere). The records of 175 French men with AIPC, over the age of 75 years, were retrospectively examined. All of the men were treated [...]

Massage Therapy- Pain Relief and Mood Control

According to a recent study in the Sept. 16 "Annals of Internal Medicine"; survivors coping with advanced cancer receive some relief from pain and depression from massage therapy. The researchers found that survivors who received massage from a licensed, specially trained therapist reported greater improvements in pain and mood symptoms than did people who received [...]

Cancer Politics in the 2008 Election – A Discussion

Have you thought about how your vote might lead to better cancer treatments, research funding and prevention programs? Tomorrow, Tuesday, you can listen to a conversation among cancer care advocates about the upcoming U.S. presidential election and what your vote could mean for us prostate cancer survivors. Topics will include healthcare plans, environmental protection and [...]

By |2020-02-04T09:48:52-05:00September 15th, 2008|Advanced Prostate Cancer, Politics of Cancer, Uncategorized|0 Comments

Pain – There Is No Reason To Be In Pain

Taking charge of your medical care not only might improve your survival, but it could also improve your life. According to a study in the September 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology pain is the most common symptom of cancer, [...]

Cancer and the Presidential Campaign

The presidential campaign season is now officially upon us and we are being besieged by both political parties as they ask for our financial support and our vote. When you consider which of the candidates to support you should factor into your decision their plans about cancer. Both of the presidential campaigns have released plans [...]

Go to Top